While SK still has to wait until 2027 to manufacture and sell SKYPneumo in Korea, the company plans to “initiate new business in pneumococcal conjugate vaccines” by exporting individual components of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results